K-numberK242909
Device nameFloTrac sensors; FloTrac Jr sensors; Acumen IQ sensors; VolumeView sensors
ApplicantEdwards Lifesciences, LLC
Product codeDRS
Device classClass II
Decision dateMar 21, 2025
DecisionSubstantially Equivalent
Regulation870.2850
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

These are four related disposable pressure transducer sensors (FloTrac, FloTrac Jr, Acumen IQ, and VolumeView) that convert mechanical pressure signals to electrical signals for intravascular pressure monitoring and cardiac output measurement. FloTrac and Acumen IQ are for adults; FloTrac Jr is for pediatric patients ≥12 years; VolumeView is for intravascular pressure monitoring. All sensors are constructed with a pressure-sensitive silicon chip, polycarbonate housing with integral stopcock and flush device, and connect via cable to a patient monitor.

Technological characteristics

The subject devices are identical to predicate devices in intended use, indications, and technological characteristics, with the exception of changed pressure tubing and IV set component materials. The core sensor design—silicon chip with electrodes, polycarbonate housing, stopcock, and flush mechanism—remains unchanged from the predicates.

Test standards cited

Biocompatibility testing per ISO 10993-1:2018 (Biological evaluation of medical devices – Part 1: Evaluation and testing within a risk management process) and FDA guidance issued September 4, 2020. Performance verification per Edwards' current design requirements; shelf-life and sterilization validations per existing specifications.

Substantial equivalence argument

The devices meet substantial equivalence because the only material differences from predicates are the pressure tubing and IV set components, which do not raise new safety or effectiveness concerns. Risk analysis and performance verification testing confirmed the devices meet established acceptance criteria and perform equivalently to their predicates (K152980 and K231248) despite these component material changes.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →